What stage of kidney disease is indicated by a Glomerular Filtration Rate (GFR) of 11?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 29, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

GFR of 11 Indicates Stage 5 Chronic Kidney Disease (End-Stage Kidney Disease)

A glomerular filtration rate (GFR) of 11 mL/min/1.73 m² definitively classifies as Stage 5 chronic kidney disease (CKD), also known as kidney failure or end-stage kidney disease. 1

Classification of CKD Stages Based on GFR

CKD is staged according to GFR levels as follows:

  • Stage 1: GFR ≥90 mL/min/1.73 m² with evidence of kidney damage
  • Stage 2: GFR 60-89 mL/min/1.73 m² with evidence of kidney damage
  • Stage 3a: GFR 45-59 mL/min/1.73 m²
  • Stage 3b: GFR 30-44 mL/min/1.73 m²
  • Stage 4: GFR 15-29 mL/min/1.73 m²
  • Stage 5: GFR <15 mL/min/1.73 m² or requiring kidney replacement therapy 1

Clinical Implications of Stage 5 CKD

With a GFR of 11 mL/min/1.73 m², this patient has severely decreased kidney function that requires:

  1. Immediate nephrology referral - Guidelines clearly state that patients with eGFR <30 mL/min/1.73 m² should be referred to a nephrologist 1

  2. Preparation for renal replacement therapy - At this GFR level, the patient is approaching the need for dialysis or transplantation 2

  3. Medication adjustments - Many medications require dose adjustment or discontinuation at this level of kidney function 1

  4. Close monitoring - The patient requires frequent monitoring (recommended 3-4 times per year) as indicated by the "dark red" risk category in CKD progression grids 1

Mortality and Morbidity Considerations

Stage 5 CKD is associated with significantly increased risks:

  • Cardiovascular mortality - CKD is an independent risk factor for cardiovascular events and death 1
  • Progression to dialysis dependence - Without intervention, continued decline in kidney function is likely 3
  • Uremic complications - Including metabolic acidosis, electrolyte abnormalities, and uremic symptoms 4

Management Priorities

For a patient with GFR of 11 mL/min/1.73 m²:

  1. Nephrology consultation is mandatory for specialized care and dialysis planning 1

  2. Dietary management - Protein intake should be aimed at 0.8 g/kg body weight per day for non-dialysis dependent patients 1

  3. Medication optimization:

    • Consider SGLT2 inhibitors if GFR ≥20 mL/min/1.73 m² 1
    • Adjust or discontinue medications cleared by the kidneys
    • Review for nephrotoxic medications that should be avoided
  4. Vascular access planning if dialysis is anticipated

  5. Transplant evaluation if the patient is a candidate

Common Pitfalls to Avoid

  1. Delayed nephrology referral - This is associated with worse outcomes and should be avoided 5

  2. Relying solely on GFR for dialysis initiation - The decision to start dialysis should not be based on GFR alone but should include assessment of uremic symptoms 2

  3. Failure to discuss all treatment options - Including hemodialysis, peritoneal dialysis, transplantation, and conservative management 2

  4. Inadequate medication review - Failure to adjust medications based on current renal function can lead to adverse effects 5

The patient with a GFR of 11 mL/min/1.73 m² has reached a critical stage of kidney disease requiring urgent specialist care and preparation for kidney replacement therapy or conservative management depending on individual circumstances.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation and treatment of chronic renal failure.

Indian journal of pediatrics, 1999

Guideline

Apixaban Use in Patients with Renal Impairment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.